Wells Fargo
ONCY

Wells Fargo’s Oncolytics Biotech ONCY Stock Holding History

Wells Fargo’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6K Buy
6,602
+1,201
+22% +$1.19K ﹤0.01% 6093
2025
Q4 		$4.72K Buy
5,401
+1,000
+23% +$1.08K ﹤0.01% 6110
2025
Q3 		$6.16K Hold
4,401
– – ﹤0.01% 6038
2025
Q2 		$3.4K Hold
4,401
– – ﹤0.01% 6143
2025
Q1 		$2.42K Hold
4,401
– – ﹤0.01% 6131
2024
Q4 		$4.02K Hold
4,401
– – ﹤0.01% 6098
2024
Q3 		$3.83K Hold
4,401
– – ﹤0.01% 5964
2024
Q2 		$4.36K Hold
4,401
– – ﹤0.01% 5895
2024
Q1 		$4.67K Sell
4,401
-263
-6% -$294 ﹤0.01% 5902
2023
Q4 		$6.3K Sell
4,664
-1,537
-25% -$2.4K ﹤0.01% 5925
2023
Q3 		$13.5K Hold
6,201
– – ﹤0.01% 5727
2023
Q2 		$16.1K Buy
6,201
+901
+17% +$1.5K ﹤0.01% 5798
2023
Q1 		$6.36K Buy
5,300
+1,800
+51% +$2.83K ﹤0.01% 5993
2022
Q4 		$5.71K Sell
3,500
-800
-19% -$1.22K ﹤0.01% 5730
2022
Q3 		$5K Hold
4,300
– – ﹤0.01% 5915
2022
Q2 		$4K Hold
4,300
– – ﹤0.01% 6103
2022
Q1 		$7K Buy
4,300
+2,400
+126% +$4.03K ﹤0.01% 6391
2021
Q4 		$3K Buy
1,900
+300
+19% +$555 ﹤0.01% 6811
2021
Q3 		$3K Hold
1,600
– – ﹤0.01% 6497
2021
Q2 		$4K Buy
1,600
+100
+7% +$306 ﹤0.01% 6405
2021
Q1 		$6K Buy
1,500
+500
+50% +$1.49K ﹤0.01% 6459
2020
Q4 		$2K Sell
1,000
-1,000
-50% -$2.4K ﹤0.01% 6281
2020
Q3 		$3K Sell
2,000
-1,142
-36% -$2.1K ﹤0.01% 6087
2020
Q2 		$6K Hold
3,142
– – ﹤0.01% 5944
2020
Q1 		$4K Buy
3,142
+2,500
+389% +$6.24K ﹤0.01% 5900
2019
Q4 		$3K Hold
642
– – ﹤0.01% 6132
2019
Q3 		$0 Hold
642
– – ﹤0.01% 6603
2019
Q2 		$1K Hold
642
– – ﹤0.01% 6267
2019
Q1 		$1K Hold
642
– – ﹤0.01% 5948
2018
Q4 		$1K Hold
642
– – ﹤0.01% 6290
2018
Q3 		$2K Hold
642
– – ﹤0.01% 6235
2018
Q2 		$4K Buy
+642
New +$3.95K ﹤0.01% 6112

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo's ONCY Position: Q1 2026 in Review

Wells Fargo increased its Oncolytics Biotech (ONCY) stake by 22% in Q1 2026, buying an estimated $1.19K and bringing the position to 6,602 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6093.

Wells Fargo first reported a position in ONCY in Q2 2018 and has held it in 32 quarters since. The position peaked at $16.1K in Q2 2023. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Wells Fargo held 6,602 shares of Oncolytics Biotech worth $5.6K as of Q1 2026.
  • Wells Fargo bought 1,201 Oncolytics Biotech shares in Q1 2026, an estimated $1.19K.
  • Oncolytics Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6093 holding.
  • Wells Fargo first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 32 quarters since.
  • Wells Fargo's Oncolytics Biotech position peaked at $16.1K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.